Can breast cancer drugs speed up aging? new study investigates

NCT ID NCT05700006

Completed Knowledge-focused Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study enrolled 94 women with breast cancer to see if it's possible to collect blood, stool, and survey data from older patients taking aromatase inhibitors (a type of hormone therapy). The main goal was to test the feasibility of gathering this information for future research on how these drugs might affect aging. Participants provided samples and answered questionnaires over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: aromatase inhibitor (anastrozole, exemestane, or letrozole)
What this could lead to: If successful, this study could help design larger trials that clarify how hormone therapy affects aging in older breast cancer survivors.
What could go wrong: This is a small pilot study focused on feasibility, not on proving any effects on aging. Results may not lead to changes in treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arthralgia breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGING ARTHRALGIA BREAST NEOPLASM FEMALE

Contacts and locations

Locations

University of Michigan Rogel Cancer Center

Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.